$35.76
-0.50-1.38%
마지막 업데이트: Oct 13, 4:49 AM
$35.58
-0.68-1.88%
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Medline (MDLN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $0.32 | $0.29 | $0.24 |
| Actual | $0.50 | $0.33 | $-0.01 |
| Surprise | +56.3% | +13.8% | -104.2% |
| Revenue | |||
| Estimate | $7.51B | $7.16B | $7.52B |
| Actual | $7.68B | $7.40B | $7.79B |
| Surprise | +2.29% | +3.41% | +3.62% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.34 | $0.40 | $0.30 | $0.34 |
| Revenue | ||||
| Consensus | $7.72B | $8.47B | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.50 | $0.32 | 56.3 % |
| Q1 | May 6, 2026 | $0.33 | $0.29 | 13.8 % |
| Q4 | Feb 25, 2026 | $-0.01 | $0.24 | -104.2 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $7.69B | $7.51B | 2.29 % |
| Q1 | May 6, 2026 | $7.40B | $7.16B | 3.41 % |
| Q4 | Feb 25, 2026 | $7.79B | $7.52B | 3.62 % |